YS Biopharma (NASDAQ:YS) Reaches New 12-Month High – Here’s What Happened

Shares of YS Biopharma Co., Ltd. (NASDAQ:YS) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $6.82 and last traded at $6.82, with a volume of 0 shares trading hands. The stock had previously closed at $6.82.

YS Biopharma Price Performance

The company has a debt-to-equity ratio of 0.26, a current ratio of 0.94 and a quick ratio of 0.73. The firm’s fifty day moving average price is $0.53 and its 200-day moving average price is $0.67.

Hedge Funds Weigh In On YS Biopharma

A hedge fund recently bought a new stake in YS Biopharma stock. Superstring Capital Management LP bought a new position in YS Biopharma Co., Ltd. (NASDAQ:YS) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 307,920 shares of the company’s stock, valued at approximately $166,000. Superstring Capital Management LP owned 0.33% of YS Biopharma at the end of the most recent quarter. 52.64% of the stock is owned by institutional investors.

About YS Biopharma

YS Biopharma Co, Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.